Metabolic & Intravenous Therapies
High-dose intravenous vitamin C and artemisinin
Our described protocols include intravenous vitamin C, with proposed doses ranging from 25 to 100 grams, and may include artemisinin. These interventions are being investigated for cancer-related applications; they are not established treatments for every cancer.
Before recommending treatment, we review appropriate safety testing, kidney function, medications, and compatibility with your oncology regimen. The dose range refers to vitamin C, not artemisinin.
Nutrient and antioxidant infusions
Selected preparations may include proline, glycine, taurine, lysine, B vitamins, magnesium, zinc, glutathione, and alpha-lipoic acid. We consider these ingredients according to your nutritional needs and clinical circumstances.
Antioxidant preparations require particular attention during oncology treatment because they may interact with some therapies. We do not assume that an infusion protects healthy tissue from chemotherapy.
Ozone therapy
Ozone-based procedures are included among OWM’s complementary options. Their proposed biological effects remain distinct from demonstrated cancer-treatment outcomes. We discuss the specific procedure, risks, and limitations before considering its place in your plan.
Hyperthermia & Light-Based Care
Total-body hyperthermia
This approach uses specialized equipment to raise body temperature under clinical monitoring. Our supplied protocol describes a target temperature of approximately 103.5°F during a session lasting around three hours; eligibility, temperature, and duration require individual medical assessment.
Whole-body heating carries risks and should not be presented as universally safe or as a proven way to improve the effectiveness of oncology treatment.
Targeted deep-tissue hyperthermia
OWM uses the Thermofield® system to deliver localized radiofrequency heating. We assess the proposed treatment area and explain the evidence for the specific application, including potential thermal injury. Tumor shrinkage cannot be promised.
Photodynamic therapy
Photodynamic therapy combines a photosensitizing agent with a selected wavelength of light. Our described approach may use ultrasound-guided fiberoptic placement within or near a treatment area.
Its action is photochemical rather than simply heat-based. Suitability depends on the cancer, agent, device, and protocol; established uses of photodynamic therapy do not validate every application.
Hyperbaric oxygen therapy
Our hard-shell chamber delivers oxygen at a prescribed pressure, including protocols at 2.0 ATA. We consider its role according to the clinical indication, such as selected treatment-related tissue injuries, rather than assuming that it improves tumor response or recovery in every patient.
Biologic, Digestive & Nutritional Support
Mistletoe therapy
Mistletoe extracts contain biologically active compounds studied in complementary cancer care. We review the preparation, intended purpose, evidence, and potential reactions before recommending it. Its proposed immune effects do not establish a reliable anticancer benefit.
Microbiome care and fecal microbiota therapy
We assess digestive symptoms and nutritional tolerance during treatment. Microbiota interventions are being investigated for some oncology applications, including immunotherapy response, but they are not established treatments for chemotherapy-related diarrhea or mucositis.
Rebyota® has a separate, specific approved role in preventing recurrent C. diff after antibiotic treatment in eligible adults.
Ketogenic nutrition
A carbohydrate-restricted approach may be discussed for suitable patients with oncology and nutrition-team involvement. We prioritize adequate nourishment and preservation of weight and strength.
Ketogenic diets and fasting-mimicking diets are different interventions. Neither should be described as a proven method of starving cancer cells, and dietary restriction may be inappropriate when nutritional status is compromised.
Mind-Body Support & Advocacy
Ketamine-assisted psychotherapy
For eligible patients, ketamine-assisted care may combine prescribed ketamine with preparation and integration sessions. It requires a separate mental health and medical assessment, with a discussion of risks and alternatives.
Brain Spa and mindfulness
Our Brain Spa experience may combine virtual-reality guided meditation, selected nutrient infusions, and Normatec compression. Mindfulness-Based Stress Reduction offers a complementary approach to coping and stress management.
We consider the suitability of each component individually, particularly when treatment-related medical concerns affect eligibility.
Dedicated cancer advocate
Our cancer advocate supports practical questions, coaching, nutritional implementation, and communication across your care journey. This continuing relationship helps make recommendations manageable alongside your oncology appointments.
Your Program Experience
The program begins with a comprehensive consultation and review of your oncology plan. We identify appropriate services, explain their purpose and limitations, and establish monitoring and reassessment points.
OWM describes a minimum six-week commitment, with care commonly planned across two six-week phases before consideration of a personalized maintenance program. Your proposed schedule, services, and costs are clarified before enrollment, and continuation depends on clinical review.
Our aim is coordinated support for your well-being throughout treatment. Complementary care does not replace or delay recommended oncology treatment, and outcomes cannot be guaranteed.
